메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
저널정보
전남대학교 의과학연구소 전남의대학술지 전남의대학술지 제51권 제1호
발행연도
2015.1
수록면
26 - 32 (7page)

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
This retrospective study was performed to analyze the long-term outcome of topicalcorticosteroid treatment for severe dry eye associated with Sjögren’s syndrome (SS). Patients who had severe dry eye associated with SS were topically treated with loteprednoletabonate 0.5% (group A, n=66) or fluorometholone 0.1% (group B, n=67) twicedaily and were followed up for 2 years. Visual acuity (VA), intraocular pressure (IOP),Schirmer test, tear film breakup time (BUT), keratoepitheliopathy, and symptomscores were measured at baseline and 6, 12, 18, and 24 months after treatment. VAand IOP were not changed significantly during follow-up in either group. Schirmer testresults, keratoepitheliopathy, and symptom scores at 6, 12, 18, and 24 months (p<0.05)and tear film BUT at 12, 18, and 24 months (p<0.05) significantly improved after treatmentcompared with baseline in both groups. No significant differences between thegroups were found in any parameter during follow-up. At 24 months, the number ofpatients with IOP elevation of more than 2 mmHg compared with baseline was 4 ingroup A (6.1%) and 9 in group B (13.4%). The mean IOP in these patients was lowerin group A than in group B (15.00±0.82 mmHg versus 16.50±1.12 mmHg; p=0.04). Long-term application of low-dose topical corticosteroids is effective for controllingsigns and symptoms of chronic, severe dry eye associated with SS. Loteprednol etabonate0.5% may have a lower risk for IOP elevation than fluorometholone 0.1%.

목차

등록된 정보가 없습니다.

참고문헌 (0)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0